Caitlin M. Gillis

Caitlin M. Gillis

Auto-generated profile, based on publicly available information

Caitlin M. Gillis

Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERMF-75015, Paris, France

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
FJFriederike Jönsson
Friederike Jönsson
LCLuc de Chaisemartin
Luc de Chaisemartin
VGVanessa Granger
Vanessa Granger
AGAurelie Gouel-Cheron
Aurelie Gouel-Cheron
CGCaitlin M. Gillis
Caitlin M. Gillis
PBPierre Bruhns
Pierre Bruhns
Co-existence of drug-specific IgE and IgG antibodies aggravates neuromuscular-blocking agent-induced anaphylaxis in humans.

6 April 2017 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
LRLaurent L. Reber
Laurent L. Reber
CGCaitlin M. Gillis
Caitlin M. Gillis
PSPhilipp Starkl
Philipp Starkl
FJFriederike Jönsson
Friederike Jönsson
RSRiccardo Sibilano
Riccardo Sibilano
SGStephen J. Galli
Stephen J. Galli
Neutrophils have crucial antimicrobial functions but are also thought to contribute to tissue injury upon exposure to bacterial products, such as lipopolysaccharide (LPS). To study the role of neutrophils in LPS-induced endotoxemia, we developed a new mouse model, PMNDTR mice, in which injection of diphtheria toxin induces selective neutrophil ablation. Using this model, we found, surprisingly, that neutrophils serve to protect the host from LPS-induced lethal inflammation. This protective role was observed in conventional and germ-free animal facilities, indicating that it does not depend on a particular microbiological environment. Blockade or genetic deletion of myeloperoxidase (MPO), a key neutrophil enzyme, significantly increased mortality after LPS challenge, and adoptive transfer experiments confirmed that neutrophil-derived MPO contributes importantly to protection from endotoxemia. Our findings imply that, in addition to their well-established antimicrobial properties, neutrophils can contribute to optimal host protection by limiting the extent of endotoxin-induced inflammation in an MPO-dependent manner.

1 January 2017 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
HBHéloïse Beutier
Héloïse Beutier
CGCaitlin M. Gillis
Caitlin M. Gillis
BIBruno Iannascoli
Bruno Iannascoli
OGOphélie Godon
Ophélie Godon
PEPatrick England
Patrick England
FJFriederike Jönsson
Friederike Jönsson

6 November 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
Chang Han LeeChang Han Lee
Chang Han Lee
Tae Hyun KangTae Hyun Kang
Tae Hyun Kang
OGOphélie Godon
Ophélie Godon
MWMakiko Watanabe
Makiko Watanabe
GDGeorge Delidakis
George Delidakis
GGGeorge Georgiou
George Georgiou
The pharmacokinetic properties of antibodies are largely dictated by the pH-dependent binding of the IgG fragment crystallizable (Fc) domain to the human neonatal Fc receptor (hFcRn). Engineered Fc domains that confer a longer circulation half-life by virtue of more favorable pH-dependent binding to hFcRn are of great therapeutic interest. Here we developed a pH Toggle switch Fc variant containing the L309D/Q311H/N434S (DHS) substitutions, which exhibits markedly improved pharmacokinetics relative to both native IgG1 and widely used half-life extension variants, both in conventional hFcRn transgenic mice and in new knock-in mouse strains. engineered specifically to recapitulate all the key processes relevant to human antibody persistence in circulation, namely: (i) physiological expression of hFcRn, (ii) the impact of hFcγRs on antibody clearance and (iii) the role of competing endogenous IgG. DHS-IgG retains intact effector functions, which are important for the clearance of target pathogenic cells and also has favorable developability.

1 April 2017 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
CGCaitlin M. Gillis
Caitlin M. Gillis
FJFriederike Jönsson
Friederike Jönsson
DMDavid A. Mancardi
David A. Mancardi
NTNaxin Tu
Naxin Tu
HBHéloïse Beutier
Héloïse Beutier
PBPierre Bruhns
Pierre Bruhns
Anaphylaxis can proceed through distinct IgE- or IgG-dependent pathways, which have been investigated in various mouse models. We developed a novel mouse strain in which the human low-affinity IgG receptor locus, comprising both activating (hFcγRIIA, hFcγRIIIA, and hFcγRIIIB) and inhibitory (hFcγRIIB) hFcγR genes, has been inserted into the equivalent murine locus, corresponding to a locus swap. We sought to determine the capabilities of hFcγRs to induce systemic anaphylaxis and identify the cell types and mediators involved. hFcγR expression on mouse and human cells was compared to validate the model. Passive systemic anaphylaxis was induced by injection of heat-aggregated human intravenous immunoglobulin and active systemic anaphylaxis after immunization and challenge. Anaphylaxis severity was evaluated based on hypothermia and mortality. The contribution of receptors, mediators, or cell types was assessed based on receptor blockade or depletion. The human-to-mouse low-affinity FcγR locus swap engendered hFcγRIIA/IIB/IIIA/IIIB expression in mice comparable with that seen in human subjects. Knock-in mice were susceptible to passive and active anaphylaxis, accompanied by downregulation of both activating and inhibitory hFcγR expression on specific myeloid cells. The contribution of hFcγRIIA was predominant. Depletion of neutrophils protected against hypothermia and mortality. Basophils contributed to a lesser extent. Anaphylaxis was inhibited by platelet-activating factor receptor or histamine receptor 1 blockade. Low-affinity FcγR locus-switched mice represent an unprecedented model of cognate hFcγR expression. Importantly, IgG-related anaphylaxis proceeds within a native context of activating and inhibitory hFcγRs, indicating that, despite robust hFcγRIIB expression, activating signals can dominate to initiate a severe anaphylactic reaction.

28 November 2014 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
MFManuela Flórido
Manuela Flórido
RPRoman Pillay
Roman Pillay
CGCaitlin M. Gillis
Caitlin M. Gillis
YXYingju Xia
Yingju Xia
STStephen Turner
Stephen Turner
WBWarwick Britton
Warwick Britton
Tuberculosis remains a global health problem, in part due to failure of the currently available vaccine, BCG, to protect adults against pulmonary forms of the disease. We explored the impact of pulmonary delivery of recombinant influenza A viruses (rIAVs) on the induction of Mycobacterium tuberculosis (M. tuberculosis)‐specific CD4+ and CD8+ T‐cell responses and the resultant protection against M. tuberculosis infection in C57BL/6 mice. Intranasal infection with rIAVs expressing a CD4+ T‐cell epitope from the Ag85B protein (PR8.p25) or CD8+ T‐cell epitope from the TB10.4 protein (PR8.TB10.4) generated strong T‐cell responses to the M. tuberculosis‐specific epitopes in the lung that persisted long after the rIAVs were cleared. Infection with PR8.p25 conferred protection against subsequent M. tuberculosis challenge in the lung, and this was associated with increased levels of poly‐functional CD4+ T cells at the time of challenge. By contrast, infection with PR8.TB10.4 did not induce protection despite the presence of IFN‐γ‐producing M. tuberculosis‐specific CD8+ T cells in the lung at the time of challenge and during infection. Therefore, the induction of pulmonary M. tuberculosis epitope‐specific CD4+, but not CD8+ T cells, is essential for protection against acute M. tuberculosis infection in the lung.